News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Androgen Receptor Inhibition Increases MHC Class I Expression in Prostate Cancer
Dec 11, 2024, 05:14

Androgen Receptor Inhibition Increases MHC Class I Expression in Prostate Cancer

Elizabeth McKenna, Executive Director of Cancer Discovery at the American Association for Cancer Research, shared a post on X:

“Now online in Cancer Discovery Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer -by Lisa Chesner, Felix Feng, Amy Moran, and colleagues.”

Elizabeth McKenna

Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer.

Authors: Lisa N. Chesner, Fanny Polesso, Julie N. Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg, Rajdeep Das, Tanushree Shenoy, Martin Sjöström, Faming Zhao, Ya-Mei Hu, Simon Linder, William S. Chen, Reed M. Hawkins, Raunak Shrestha, Xiaolin Zhu, Adam Foye, Haolong Li, Lisa M. Kim, Megha Bhalla, Thomas O’loughlin, Duygu Kuzuoglu-Ozturk, Junjie T. Hua, Michelle L. Badura, Scott Wilkinson, Shana Y. Trostel, Andries M. Bergman, Davide Ruggero, Charles G. Drake, Adam G. Sowalsky, Lawrence Fong, Matthew R. Cooperberg, Wilbert Zwart, Xiangnan Guan, Alan Ashworth, Zheng Xia, David A. Quigley, Luke A. Gilbert, Felix Y. Feng, Amy E. Moran.

MHC

Adam Foye Adam G. Sowalsky Alan Ashworth Alexis K. Smith Amy E. Moran Amy Moran Andries M. Bergman Androgen Receptor Arian Lundberg cancer Cancer Discovery Charles G. Drake David A. Quigley Davide Ruggero Duygu Kuzuoglu-Ozturk Elizabeth McKenna Faming Zhao Fanny Polesso Felix Feng Felix Y. Feng Haolong Li Jessica E. Hawley Julie N. Graff Junjie T. Hua Lawrence Fong Lisa Chesner Lisa M. Kim Lisa N. Chesner Luke A. Gilbert Martin Sjöström Matthew R. Cooperberg Megha Bhalla Michelle L. Badura OncoDaily Oncology prostate cancer Rajdeep Das Raunak Shrestha Reed M. Hawkins Scott Wilkinson Shana Y. Trostel Simon Linder Tanushree Shenoy Thomas O'loughlin Wilbert Zwart William S. Chen Xiangnan Guan Xiaolin Zhu Ya-Mei Hu Zheng Xia
Special Coverage
Blog
May 6, 2025, 01:34
Gerry Hanna: First study to show that hippocampus avoidance during WBRT may reduce depression rates
Blog
May 6, 2025, 01:21
Felipe Couñago: First RAPID-RT analysis at ESTRO25
Blog
May 6, 2025, 00:26
Ane Appelt: Amazing work by Max Tanaka from NKI at ESTRO25
Blog
May 5, 2025, 23:22
Giulio Francolini: Wonderful morning session about management of BCR in prostate cancer at ESTRO 2025
Blog
May 5, 2025, 17:25
Alizée Camps Maléa Highlights EMBRACE II Cervix Cancer Study at ESTRO25
Blog
May 5, 2025, 16:58
Gian Marco Petrianni: The ESTRO Re-irradiation Focus Group is born
Career
May 5, 2025, 16:13
Linda Carlson Co-Leads CAN-PACT Psychedelic Therapy Network Backed by $5.4M Grant - SIO
Blog
May 5, 2025, 16:04
Immunotherapy with Chemoradiotherapy Reduces Surgical Need in Rectal Cancer - ESTRO
Blog
May 5, 2025, 15:55
Ethiopian Society of Hematology and Oncology Announces the 5th Annual Conference at Adwa Museum
Blog
May 5, 2025, 15:50
Giulia Marvaso Highlights Evolving Evidence on SBRT and MDT Strategies at ESTRO25
Blog
May 5, 2025, 15:42
Wafik S. El-Deiry Reflects on Paul Calabresi's Legacy and NCI K12 Award Challenges
Blog
May 5, 2025, 15:40
Mona Arbab Highlights Asal Rahimi’s Talk on SPBI and Preop RT in Early Stage Breast Cancer